# Post Marketing Clinical Trial to Demonstrate the Performance of the MedHub AutocathFFR Device.

Study · id `cardio:ct-nct04724057` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04724057](<https://clinicaltrials.gov/study/NCT04724057>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04724057

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 488 participants.

## Technical summary

Registry record NCT04724057. Allocation not applicable; no masking; primary purpose other. Start 2021-06-01 (anticipated); primary completion 2021-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 488 participants (planned count; ClinicalTrials.gov record NCT04724057, source copy `cardio:ctgov-nct04724057-2021-04-20`, retrieved 2026-10-26)
- Planned start: 2021-06-01 (anticipated) (ClinicalTrials.gov record NCT04724057, source copy `cardio:ctgov-nct04724057-2021-04-20`, retrieved 2026-10-26)
- Primary completion: 2021-06-01 (anticipated) (ClinicalTrials.gov record NCT04724057, source copy `cardio:ctgov-nct04724057-2021-04-20`, retrieved 2026-10-26)
- Completion: 2021-08-01 (anticipated) (ClinicalTrials.gov record NCT04724057, source copy `cardio:ctgov-nct04724057-2021-04-20`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04724057-2021-04-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Post Marketing Clinical Trial to Demonstrate the Performance of the MedHub AutocathFFR Device.
- Condition: Coronary Artery Disease
- Intervention (Device): AutocathFFR
- Lead sponsor: Medhub Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 3cbf828768b3a886b5ee436adf9e1b5e44005d7cef6720a8707b75631a0dc053
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
